SEOUL, South Korea, June 9, 2026 /PRNewswire/ -- Beauty of Joseon has been recognized by global market intelligence company Euromonitor International as the "Global No.1...
SEOUL, South Korea, June 9, 2026 /PRNewswire/ -- Beauty of Joseon has been recognized by global market intelligence company Euromonitor International as the "Global No.1...
(UPM, Helsinki, June 8, 2026 at 14:00 EEST) HELSINKI, June 8, 2026 /PRNewswire/ -- UPM is simplifying adhesive selection with purpose-built solutions designed for demanding...
The Korean specialty ingredient company - Shinsung Materials - expands its portfolio across preservative systems, UV solutions, oil thickeners, and emulsifiersSEOUL, South Korea, June...
NANJING, China, June 5, 2026 /PRNewswire/ -- NTRK gene fusions have been identified as oncogenic drivers in adult and pediatric patients with pan-solid tumors....
The iconic Seoul-based brand introduces a first-of-its-kind flagship where cutting-edge architecture meets AI-based, made-for-you beautySEOUL, South Korea, June 5, 2026 /PRNewswire/ -- After 18 months...
DELRAY BEACH, Fla., June 4, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the biofertilizer market is projected to grow from USD 4.08 billion in 2026 and to...
DELRAY BEACH, Fla., June 4, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the biofertilizer market is projected to grow from USD 4.08 billion in 2026 and to...
TAIPEI, June 4, 2026 /PRNewswire/ -- Compal Electronics (Compal; TWSE: 2324) showcases its landmark achievements in Quantum Technology and Advanced Artificial Intelligence (AI) at COMPUTEX...
MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (“Celcuity” or the “Company”), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor indications, today announced the pricing of its upsized underwritten public offering of $500,000,000 aggregate principal amount of its 0.250% convertible senior notes due 2032 (the “Convertible Notes”). The aggregate principal amount of the offering was increased from the previously announced offering size of $400,000,000.
New collaboration delivers a fully integrated formulation workflow from early solubility studies to high-throughput dissolution, stability, and in-process analytics, making drug formulation less artisanal...